FdaApplication
ANDA 062717
Identifiers
- fda_app_no: ANDA062717
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH AYERST LABORATORIES |
| application_type | ANDA |
| approval_date | 1986-12-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UNIPEN | NAFCILLIN SODIUM | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| UNIPEN | NAFCILLIN SODIUM | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| UNIPEN | NAFCILLIN SODIUM | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
3 products